Your session is about to expire
← Back to Search
Warfarin Self-Management for Anticoagulation Therapy
Study Summary
This trial is testing whether letting patients manage their own warfarin therapy is less burdensome, less expensive, and safer than standard clinic-directed warfarin management.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not speak English.I am 18 or older and have been on warfarin for at least 9 months.I am expected to be on warfarin for at least 6 months.My target INR is not between 2.0-3.0 or 2.5-3.5.I have had trouble following my warfarin treatment plan.
- Group 1: Warfarin Patient Self-Management
- Group 2: Historical Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What goals is this trial attempting to achieve?
"This clinical trial, tracked over a 6-month period, is focused on attaining Time in therapeutic INR range (TTR). Secondary goals include assessing Episodes of thromboembolic complications, Episodes of major bleeding as defined by the ISTH definition, and Anticoagulation therapy knowledge scores generated from an Anticoagulation Knowledge Survey Tool."
Is enrollment for this trial still open?
"The clinicaltrial.gov website confirms that this medical study is not enrolling patients at present, though it was initially posted on September 1st 2022 and updated last on the 27th of September 2021. Nonetheless, there are 603 other trials actively recruiting individuals as we speak."
Share this study with friends
Copy Link
Messenger